Triovobs 2mg/500mg/0.2mg Tablet SR
Marketer
Ridgecure Pharma
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Triovobs 2mg/500mg/0.2mg Tablet SR
Diabetic patients using the extended-release formulation of Triovobs (2mg/500mg/0.2mg) should be aware that this antidiabetic medication combines multiple agents for effective type 2 diabetes management in adults. Its primary function is blood glucose regulation. Always take this medication with food, consistently at the same time daily for optimal results. Dosage adjustments, determined by your physician based on your blood glucose levels, may occur. Continuous use is crucial; discontinuation without medical guidance risks elevated blood sugar, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by symptoms such as sweating, dizziness, headache, and tremors. Prompt treatment with fast-acting glucose, like sugary foods or juice, is vital. Regular meals are essential for prevention, and alcohol should be avoided due to its hypoglycemic potential. Additional potential side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also possible. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should consult their doctor before starting this medication. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is necessary, and your physician may order blood tests to assess blood cell counts and liver function.
Uses of Triovobs 2mg/500mg/0.2mg Tablet SR
Managing Type 2 Diabetes
Major Benefits of Triovobs 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Triovobs 2mg/500mg/0.2mg Tablet SR. Swallow the tablet whole; do not crush, chew, or break it. Administer this medication on an empty stomach.
Common Side effects of Triovobs 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Triovobs 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Administer Triovobs 2mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
How Triovobs 2mg/500mg/0.2mg Tablet SR works:
The extended-release tablet Triovobs, containing 2mg/500mg/0.2mg of three distinct antidiabetic agents, is a combined formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Triovobs 2mg/500mg/0.2mg SR tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Triovobs 2mg/500mg/0.2mg SR Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Triovobs tablet (2mg/500mg/0.2mg) is likely unsafe for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Employing Triovobs 2mg/500mg/0.2mg Tablet SR carries a high risk for individuals with kidney impairment and is best avoided. Medical advice is recommended. Furthermore, its use is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Triovobs 2mg/500mg/0.2mg SR tablets cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should typically begin with a reduced dosage. The medication is contraindicated in patients exhibiting severe hepatic dysfunction. Consult a physician for guidance.
What if you forget to take Triovobs 2mg/500mg/0.2mg Tablet SR :
Should you forget to take a Triovobs 2mg/500mg/0.2mg Tablet SR, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Triovobs 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently